To investigate whether these survival differences seen in our mouse models had clinical relevance, we assessed the relationship between overall survival and IL13RA2 levels in a cohort of patients with basal-like breast cancer (n = 309) using KM Plotter [49]. This evidence concerns the gene IL13RA2 and breast cancer.